R. Perez-Carrión
3 Papers
2 Citations
R. Perez-Carrión is an academic researcher. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
Nerea Martinez,M. Herrera,L. Frías,Mariano Provencio,R. Perez-Carrión,V. Díaz,Michael A. Morse,M. C. Crespo +7 more
TL;DR: The combination of hydroxytyrosol, omega-3 fatty acids, and curcumin reduced inflammation as indicated by a reduction in CRP and reduced pain in patients with aromatase-induced musculoskeletal symptoms.
89
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies
Teresa Moran,J. Wei,M. Cobo,X. Qian,Manuel Domine,Z. Zou,Isabel Bover,Liang Wang,Mariano Provencio,L. Yu,Imane Chaib,C. You,B. Massuti,Y. Song,A. Vergnenegre,H. Lu,Guillermo Lopez-Vivanco,W. Hu,Gilles Robinet,J. Yan,A. Insa,X. Xu,Margarita Majem,X. Chen,R. de las Peñas,Niki Karachaliou,M.A. Sala,Q. Wu,Dolores Isla,Y. Zhou,Nathalie Baize,F. Zhang,J. Garde,P. Germonpre,S. Rauh,H. ALHusaini,Maria Sanchez-Ronco,Ana Drozdowskyj,Jose Javier Sanchez,Carlos Camps,B. Liu,Rafael Rosell,B. Colinet,J. De Greve,H. Chen,J. Du,Y. Gao,J. Hu,W. Kong,L. Li,R. Li,X. Li,J. Liu,W. Ren,L. Wen,X. Xiao,J. Yang,M. Yang,Y. Yang,J. Yin,X. Yue,J. Zhang,L. Zhu,P. Bombaron,Christos Chouaid,Eric Dansin,P. Fournel,G. Fraboulet,Radj Gervais,S. Hominal,S. Kahlout,H. Lecaer,Hervé Lena,J. LeTreut,C. Locher,Olivier Molinier,Isabelle Monnet,G. Oliviero,R. Schoot,P. Thomas,G. Berchem,H. Al Husaini,Francisco Aparisi,Edurne Arriola,I. Ballesteros,Isidoro Barneto,R. Bernabé,Ana Blasco,Joaquim Bosch-Barrera,V. Calvo de Juan,Enric Carcereny,Silvia Catot,Enriqueta Felip,M.-R. García-Campelo,C. García-Girón,Ramon Garcia-Gomez,R. Garcia-Sevila,A. Gasco,J. Gil,Jose-Luis Gonzalez-Larriba,S. Hernando-Polo,E. Jantus,B. Jiménez,Pilar Lianes,R. López-López,A. López-Martín,Jose Antonio Macias,J.L. Marti-Ciriquian,R. Montoyo,Daniela Morales-Espinosa,Miguel Angel Moreno,Cinta Pallares,Marta Parera,R. Perez-Carrión,R. Porta,Noemí Reguart,F. Rosillo,J.M. Sanchez,I. Sullivan,J. Terrasa,Jose Manuel Trigo,Javier Valdivia,Nuria Viñolas,Santiago Viteri,M. Botia-Castillo,José-Luis Mate,M. Perez-Cano,Josep Ramírez,B. Sanchez-Rodriguez,Miquel Taron,M. Tierno-Garcia,E. Mijangos,J. Ocaña,E. Pereira,J. Shao,X. Sun,R. O'Brate +136 more
TL;DR: The BREC studies provide proof of concept that an international, nonindustry, biomarker-directed trial is feasible and it is expected that ongoing further research on alternative biomarkers to elucidate DNA repair mechanisms will help define novel therapeutic approaches.
27
Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives
E. Garcia-Patino,B. Gomendio,Jose M. Silva,José María Franco García,Mariano Provencio,R. Perez-Carrión,Pilar Lianes,Antonio Casado,Pilar España,Félix Bonilla +9 more
TL;DR: The prevalence rate of germline BRCA1 gene mutations among families with breast cancer syndrome is low, and relatives having the same haplotype for the 17q21 region as mutation-carrying patients usually display the same genomic sequence as the patients.
2